S100A9 and HIV infectious disease: We previously reported that CD85j+ NK cells have significantly higher capacity to control HIV infection in autologous DCs compared with CD85j− NK cells (9), and our studies suggested that the inhibition of HIV replication is due to the interaction of the receptor CD85j with a new ligand, the S100A9 molecule (10).